Intramuscular methotrexate in inflammatory rheumatic disease

摘要: We read with great interest the recent letter entitled “Is parenteral methotrexate worth trying?” by Osman and Mulherin.1 There has been an increased use of intramuscular (IM-MTX) in our department past two years, leading to workload nurse-led monitoring clinics cost. This prompted us review clinical utility switching patients IM-MTX. In addition, we have recorded patients' experiences, focusing chiefly on patient satisfaction, this treatment. Medical case notes 31 who had started treatment IM-MTX, identified from database, were examined. The diagnosis, previous drug treatment, reason for changing efficacy, side effects noted. asked complete a questionnaire, looking at satisfaction preferred venue injections (monitoring clinic or local doctor's …